EN
HI
Aarti Drugs Share price
AARTIDRUGS
369.5
1.80 (-0.48%)NSE
BSE
Last updated on 24 Feb, 2026 | 15:31 IST
BUYSELL
Today's High
371.90
Today's Low
367.65
52 Week Low
312.00
52 Week High
564.05
Free Demat with Zero AMC*
Aarti Drugs Chart
Aarti Drugs Share Key Metrics
Volume
71369.00
Market Cap
3372.43 CR
LTQ@LTP
2@369.50
ATP
369.65
Var Margin
18.47 %
Circuit Range
297.05-445.55
Delivery %
55.2 %
Value
2.64 CR
ASM/GSM
No
Market Lot
1
Summary
At 24 Feb, 2026 | 15:31, Aarti Drugs share price stands at ₹369.5, showing a 1.80% -0.48 for the day. The stock’s intraday movement has stayed between ₹367.65 and ₹371.90, while on a 52-week basis it has fluctuated from ₹312.00 to ₹564.05.
In terms of trading activity, Aarti Drugs has recorded a volume of 71369 shares, with a market capitalisation of ₹91270000. The stock’s Average Traded Price (ATP) stands at ₹36965, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2,36950. The stock operates within a circuit range of ₹297.05-445.55, with a Value of ₹2.64 CR. The Delivery Percentage for the day is 55.2%. Additionally, Aarti Drugs currently falls under the No framework, and trades with a market lot size of 1.
Aarti Drugs Fundamentals
View MoreP/E Ratio
16.79
P/B Ratio
2.25
Div. Yield
0.27
Sector P/E
63.23
Sector P/B
2.76
Sec. Div. Yield
0.57
Aarti Drugs Resistance and Support
Pivot 372.07
Resistance
First Resistance
374.94
Second Resistance
378.57
Third Resistance
381.44
Support
First Support
368.44
Second Support
365.57
Third Support
361.94
Aarti Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-03 | Quarterly Results & Interim Dividend |
| 2025-11-07 | Quarterly Results |
| 2025-07-18 | Quarterly Results |
| 2025-05-06 | Audited Results |
| 2025-01-29 | Quarterly Results & Interim Dividend |
Aarti Drugs News
Aarti Drugs shares in focus after 7 observations from USFDA
Sep 23 2024 08:16:52
Read More
About Aarti Drugs
NSE : 4481
BSE : 524348
ISIN : INE767A01016
Aarti Drugs Management
| Name | Position |
|---|---|
| Mr. Chandrakant V Gogri | Chairman Emeritus |
| Mr. Prakash M Patil | Chairman & M.D & CEO |
Aarti Drugs Similar Stocks
Indraprastha Medical Corporation Ltd.
401.30
-7.50 (1.83%)
Senores Pharmaceuticals Ltd.
780.80
-13.00 (1.64%)
Suven Life Sciences Ltd.
149.45
-1.50 (0.99%)
Advanced Enzyme Technologies Ltd.
308.60
-5.30 (1.69%)
SMS Pharmaceuticals Ltd.
380.80
5.50 (1.47%)
Orchid Pharma Ltd.
653.50
-11.80 (1.77%)
Gujarat Themis Biosyn Ltd.
319.30
-14.65 (4.39%)
RPG Life Sciences Ltd.
1882.30
-26.30 (1.38%)
Gufic Biosciences Ltd.
281.10
-2.40 (0.85%)
Dishman Carbogen Amcis Ltd.
180.50
-0.79 (0.44%)
Aarti Drugs FAQs
The Buying Price of Aarti Drugs share is 369.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Drugs shares is 16.79. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Drugs shares is 2.25. Useful to assess the stock's value relative to its book value.
To assess Aarti Drugs’s valuation compare Sector P/E, P/B which are 63.23 & 2.76 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Drugs is 3372.43 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Drugs share price is 564.05 & 312.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Drugs belongs to the Healthcare sector.
